Conveners
Session 24a - Combined Therapies: Including Immunotherapy
- Kirsten Hopkins (IAEA)
- Felipe Calvo
Description
Learning objectives:
1. To learn about the use of combined therapies in a practical setting
Albert Nyamhunga
(Parirenyatwa Group of Hospitals)
6/23/17, 11:20 AM
Clinical Radiation Oncology
Oral Presentation
**Background and Purpose:** Invasive cancer of the uterine cervix is the most common cancer and the leading cause of cancer-related mortality among Zimbabwean black female population. A high HIV prevalence of 43.5% has been reported among our cervical cancer patients in an unpublished retrospective study. HIV positive population tends to present with cancers at a younger age with more advanced...
Primož Strojan
(Institute of Oncology Ljubljana)
6/23/17, 11:30 AM
Clinical Radiation Oncology
Oral Presentation
**Introduction of the study:** In LASCCHN, a combination of radiotherapy (RT) and CMb: (1) significantly improves overall survival rate compared with RT alone; (2) CMb-treated patients with a prominent CMb-induced rash survived significantly better than patients with no or grade 1 rash, who experience no survival advantage compared to irradiated only patients. Comparing the benefits of...
Shiro Obata
(Nagasaki Prefecture Shimabara Hospital)
6/23/17, 11:40 AM
Oral Presentation
Introduction of the study:
We have experienced a new multidisciplinary treatment strategy for advanced rectal cancers: a chemo-radiotherapy with a new radio-sensitizer, which is antioxidant enzymes-targeting drug to induce hypoxic cancer cells (a cause of treatment resistance) re-oxygenation, infusion by endoscopic guide with the approval of our Ethical Review Board and evaluated the safety...
